| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/21/1997 | WO1997030058A1 Phosphatidyl oligoglycerols |
| 08/21/1997 | WO1997030024A2 Lipids and their use, for example, in liposomes |
| 08/21/1997 | WO1997029842A1 Solid and semi-solid hydrocarbon gels and uses thereof |
| 08/21/1997 | WO1997029783A1 Improvements in or relating to contrast agents |
| 08/21/1997 | WO1997029782A1 Thermally stabilized contrast agent |
| 08/21/1997 | WO1997029779A2 Egf-genistein conjugates for the treatment of cancer |
| 08/21/1997 | WO1997029778A2 Bioresponsive pharmacologically-active polymers and articles made therefrom |
| 08/21/1997 | WO1997029777A1 Drug delivery system using galactoxyloglucan |
| 08/21/1997 | WO1997029767A1 Stabilised growth hormone formulation and method of preparation thereof |
| 08/21/1997 | WO1997029763A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
| 08/21/1997 | WO1997029752A1 Storage-stable prostaglandin compositions |
| 08/21/1997 | WO1997029735A1 Dermal penetration enhancers and drug delivery systems involving same |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | DE19622224A1 Phosphatidyloligoglycerine Phosphatidyloligoglycerols |
| 08/21/1997 | DE19608354A1 Biodegradable polymer inclusion compounds of renewable raw material with good, variable mechanical properties |
| 08/21/1997 | CA2246778A1 Thermally stabilized contrast agent |
| 08/21/1997 | CA2246371A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
| 08/21/1997 | CA2242488A1 Conjugation of polypeptides |
| 08/20/1997 | EP0790312A2 Target cell specific vectors for the insertion of genes into cells, medicament containing such vectors and their use |
| 08/20/1997 | EP0789780A1 Methods and reagents for the identification and regulation of senescence-related genes |
| 08/20/1997 | EP0789715A1 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789708A1 Multifunctional molecular complexes for gene transfer to cells |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789590A2 Chitosan induced immunopotentiation |
| 08/20/1997 | EP0789589A1 Composition, device, and method for electrotransport agent delivery |
| 08/20/1997 | EP0789587A1 Combined meningitis vaccine |
| 08/20/1997 | EP0789586A1 Compounds for the prevention and treatment of helminth infections |
| 08/20/1997 | EP0789584A1 Application of superoxide dismutase in liposomes |
| 08/20/1997 | EP0789580A1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 08/20/1997 | EP0789572A1 Cisapride extended release oral compositions |
| 08/20/1997 | EP0789564A1 Polynucleotide compositions |
| 08/20/1997 | EP0789562A1 Sustained release caffeine formulation |
| 08/20/1997 | EP0789561A1 Oral cyclosporin formulations |
| 08/20/1997 | EP0789560A1 A novel pharmaceutical for oral administration comprising progresterone and a polyethyelene glycol together with an excipient |
| 08/20/1997 | EP0789559A1 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 08/20/1997 | EP0789558A1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
| 08/20/1997 | EP0635001B1 Substituted thioureas as bifunctional chelators |
| 08/20/1997 | EP0592511B1 Sequence-specific binding polymers for duplex nucleic acids |
| 08/20/1997 | EP0464150B1 Skin permeation enhancer compositions |
| 08/20/1997 | EP0452457B1 Method of in vivo delivery of functioning foreign genes |
| 08/20/1997 | CN1157572A Liquid immunoglobulin formulations |
| 08/20/1997 | CN1157570A Intracellular delivery of chemical agents to specific cell type |
| 08/20/1997 | CN1157563A Ointment |
| 08/20/1997 | CN1157290A Recombinant obese (ob) proteins |
| 08/19/1997 | US5659015 For enhancing serum lifetime of protein conjugates; enhancing drug delivery |
| 08/19/1997 | US5659013 Vascular permeability factor targeted compounds |
| 08/19/1997 | US5658995 Implantable medical devices and drug delivery; tensile strength |
| 08/19/1997 | US5658948 Lysine; histidine |
| 08/19/1997 | US5658898 Intravenous solutions for a derivative of staurosporine |
| 08/19/1997 | US5658879 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 08/19/1997 | US5658878 Therapeutic preparation for inhalation |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658746 Cell surface receptor complementation |
| 08/19/1997 | US5658741 Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation |
| 08/19/1997 | US5658592 Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane |
| 08/19/1997 | US5658587 Transdermal patch |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | US5658551 Stable microbubbles suspensions injectable into living organisms |
| 08/19/1997 | CA2118655C Parathyroid hormone-containing emulsion for nasal administration |
| 08/19/1997 | CA2007353C Superficial therapeutic system comprising an antineoplastic active substance, particularly 5-fluorouracil |
| 08/19/1997 | CA1339300C Sustained release microcapsule for water soluble drug |
| 08/19/1997 | CA1339295C Surface active lactams |
| 08/14/1997 | WO1997029185A1 Recombinant phages |
| 08/14/1997 | WO1997029170A1 Technical di- and triglyceride mixtures |
| 08/14/1997 | WO1997029145A1 Copolymers with polyester polycarbonate blocks containing poly(caprolactone) segments, and use thereof for the preparation of biodegradable matrices |
| 08/14/1997 | WO1997029128A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 08/14/1997 | WO1997029114A1 Biotin-containing compounds, biotinylation reagents and methods |
| 08/14/1997 | WO1997028833A1 Methods and compositions for the modulation of cell proliferation and wound healing |
| 08/14/1997 | WO1997028828A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 08/14/1997 | WO1997028824A1 Obesity protein compounds and formulations thereof |
| 08/14/1997 | WO1997028822A1 Composition and method for causing photodynamic damage to target cells |
| 08/14/1997 | WO1997028817A1 Receptor ligand-facilitated delivery of biologically active molecules |
| 08/14/1997 | WO1997028811A1 Use of arabinogalactan in a sperm wash product |
| 08/14/1997 | WO1997028801A1 Colonic delivery of nicotine to treat inflammatory bowel disease |
| 08/14/1997 | WO1997028794A1 Transparent aqueous solution of diclofenac sodium and medicinal compositions with the use of the same |
| 08/14/1997 | WO1997028793A1 External preparation containing tranilast and process for producing the same |
| 08/14/1997 | WO1997028788A1 Solid formulations containing trehalose |
| 08/14/1997 | WO1997028787A1 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 08/14/1997 | WO1997028784A1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 08/14/1997 | WO1997013489A3 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 08/14/1997 | DE19605175A1 Lipidverbindungen und deren Verwendung Lipid compounds and their use |
| 08/14/1997 | DE19604744A1 Technische Di-/Triglyceridgemische Technical di- / triglyceride |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2244792A1 Recombinant phages |
| 08/14/1997 | CA2243707A1 Obesity protein compounds and formulations thereof |
| 08/13/1997 | EP0789034A2 Biopolymers having an improved solubility in detergents |
| 08/13/1997 | EP0788794A1 Composition of external preparation |
| 08/13/1997 | EP0788792A1 Matrix type patch preparation |
| 08/13/1997 | EP0788789A1 Ranitidine compositions and their use for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
| 08/13/1997 | EP0788515A1 Non-antigenic branched polymer conjugates |
| 08/13/1997 | EP0788505A1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use |
| 08/13/1997 | EP0788383A2 Modulation of cell proliferation and wound healing |
| 08/13/1997 | EP0788375A2 Functionalized polymers for site-specific attachment |
| 08/13/1997 | EP0788374A2 Cell-specific gene delivery vehicles |
| 08/13/1997 | EP0788373A1 Novel complexes and their compositions |
| 08/13/1997 | EP0788369A1 AROMATIC COMPOSITION BASED ON OLIBANAM COMBINED WITH A SYNERGIC AGENT (e.g. EUCALYPTOL, BARNEOL, ZINC, SALT, COPPER, SALT) AND USE THEREOF |
| 08/13/1997 | EP0788354A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
| 08/13/1997 | EP0788349A1 Liposome composition containing selegilin |
| 08/13/1997 | EP0788348A1 Container with multi-phase composition for use in diagnostic and therapeutic applications |